세계의 의료용 외골격 시장 보고서 : 컴포넌트, 유형, 부위, 가동성, 최종사용자, 지역별(2024-2032년)

The global medical exoskeleton market size reached US$ 378.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,508.6 Million by 2032, exhibiting a growth rate (CAGR) of 30.73% during 2024-2032.

A medical exoskeleton is an electromechanical device that supports the human musculoskeletal system for rehabilitation and enables an injured or paraplegic person to stand and walk. It relies on a combination of springs and dampers that can store energy from human motion and reuse it when required to enhance a posture or motion. It also uses actuators that convert electrical, air, or hydraulic energy into mechanical force to support and strengthen the human movement. It is employed in the military sector to give soldiers additional protection and abilities during warfare. It is also used in the construction sector to reduce fatigue and back, neck, and shoulder pain.

Medical Exoskeleton Market Trends:

At present, the growing incidences of spinal cord injuries (SCI) due to falls, road traffic crashes, or violence represent one of the key factors driving the market. Besides this, there is a rise in the demand for medical exoskeletons in various industries to support employee health and boost productivity around the world. This, along with the rising number of startups that expertise in exoskeleton technology and provide solutions for rehabilitation, is positively influencing the market. Moreover, key market players are financing research and development (R&D) activities to introduce anti-radiation aprons for health workers suffering from neck and back problems. They are also focusing on launching a robotic partial knee orthosis used by wearers to reduce knee pain and regain mobility. In addition, the growing prevalence of musculoskeletal injuries and disorders, such as occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI), is offering a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global medical exoskeleton market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, type, extremity, mobility and end user.

Breakup by Component:

Hardware

Software

Breakup by Type:

Powered Exoskeletons

Passive Exoskeletons

Breakup by Extremity:

Lower Extremity Medical Exoskeletons

Upper Extremity Medical Exoskeletons

Full Body

Breakup by Mobility:

Mobile Exoskeletons

Stationary Exoskeletons

Breakup by End User:

Rehabilitation Centers

Physiotherapy Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being B-Temia Inc., Cyberdyne Inc., Ekso Bionics Holdings Inc., ExoAtlet Global S.A., GOGOA Mobility Robots, Hocoma AG (DIH International Limited), Myomo Inc., ReWalk Robotics Ltd, Rex Bionics Ltd., suitX Inc. (Ottobock SE & Co. KGaA), Wandercraft and Wearable Robotics Srl.

Key Questions Answered in This Report:

• How has the global medical exoskeleton market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global medical exoskeleton market?
• What are the key regional markets?
• What is the breakup of the market based on the component?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the extremity?
• What is the breakup of the market based on the mobility?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global medical exoskeleton market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Exoskeleton Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Component

• 6.1 Hardware
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Software
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Type

• 7.1 Powered Exoskeletons
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Passive Exoskeletons
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Extremity

• 8.1 Lower Extremity Medical Exoskeletons
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Upper Extremity Medical Exoskeletons
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Full Body
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Mobility

• 9.1 Mobile Exoskeletons
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Stationary Exoskeletons
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by End User

• 10.1 Rehabilitation Centers
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Physiotherapy Centers
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Others
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia-Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 B-Temia Inc.
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
  • 16.3.2 Cyberdyne Inc.
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
    • 16.3.2.3 Financials
  • 16.3.3 Ekso Bionics Holdings Inc.
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
  • 16.3.4 ExoAtlet Global S.A.
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
  • 16.3.5 GOGOA Mobility Robots
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
  • 16.3.6 Hocoma AG (DIH International Limited)
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
  • 16.3.7 Myomo Inc.
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
    • 16.3.7.3 Financials
  • 16.3.8 ReWalk Robotics Ltd
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
    • 16.3.8.3 Financials
  • 16.3.9 Rex Bionics Ltd.
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
  • 16.3.10 suitX Inc. (Ottobock SE & Co. KGaA)
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
  • 16.3.11 Wandercraft
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
  • 16.3.12 Wearable Robotics Srl
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio